Aging, Melatonin, and the Pro- and Anti-Inflammatory Networks
Open accessThe DOI matches its Crossref record; 399 of the 412 references it cites were found in a registry or an index.
Abstract
Aging and various age-related diseases are associated with reductions in melatonin secretion, proinflammatory changes in the immune system, a deteriorating circadian system, and reductions in sirtuin-1 (SIRT1) activity. In non-tumor cells, several effects of melatonin are abolished by inhibiting SIRT1, indicating mediation by SIRT1. Melatonin is, in addition to its circadian and antioxidant roles, an immune stimulatory agent. However, it can act as either a pro- or anti-inflammatory regulator in a context-dependent way. Melatonin can stimulate the release of proinflammatory cytokines and other mediators, but also, under different conditions, it can suppress inflammation-promoting processes such as NO release, activation of cyclooxygenase-2, inflammasome NLRP3, gasdermin D, toll-like receptor-4 and mTOR signaling, and cytokine release by SASP (senescence-associated secretory phenotype), and amyloid-β toxicity. It also activates processes in an anti-inflammatory network, in which SIRT1 activation, upregulation of Nrf2 and downregulation of NF-κB, and release of the anti-inflammatory cytokines IL-4 and IL-10 are involved. A perhaps crucial action may be the promotion of macrophage or microglia polarization in favor of the anti-inflammatory phenotype M2. In addition, many factors of the pro- and anti-inflammatory networks are subject to regulation by microRNAs that either target mRNAs of the respective factors or upregulate them by targeting mRNAs of their inhibitor proteins.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Inducing effect of melatonin on macrophage and microglia polarization in favor of the anti-inflammatory phenotype M2 is well known (59).”
From Melatonin Attenuates LPS-Induced Acute Depressive-Like Behaviors and Microglial NLRP3 Inflammasome Activation Through the SIRT1/Nrf2 Pathway (2019) · cites this paper as [59]
In the citing paper
“Its antioxidant and anti-inflammatory activities are exerted through the suppression of cyclooxygenase 2, NLRP3 inflammasome, gasdermin D, TLR-4, NF-kB, and NO release, as well as the concomitant activation of SIRT1 and Nrf2 free radical scavenging network [452].”
From The Role of Antioxidants in the Interplay between Oxidative Stress and Senescence (2022) · cites this paper as [452]
In the citing paper
“As a reduction in melatonin secretion has been observed during aging [452], several studies have explored the role of this hormone in counteracting cellular senescence [451].”
From The Role of Antioxidants in the Interplay between Oxidative Stress and Senescence (2022) · cites this paper as [452]
In the citing paper
“In vitro and in vivo studies demonstrate melatonin’s protective ability against mitochondria-mediated injury with hypertension and obesity, suggesting that dietary supplementation with exogenous melatonin in later years may be an effective therapeutic intervention for such age-related conditions [33].”
From Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements (2022) · cites this paper as [33]
In the citing paper
“suggesting that dietary supplementation with exogenous melatonin in later years may be an effective therapeutic intervention for such age-related conditions [33].”
From Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements (2022) · cites this paper as [33]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
11 retracted
Zou, P., Liu, X., Li, G., & Wang, Y. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.8241 · Cited by 130
RetractedShi, D., Xiao, X., Wang, J., Liu, L., Chen, W., Fu, L., Xie, F., Huang, W., & Deng, W. (2012) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2012.00982.x · Cited by 101
RetractedChuffa, L. G. A., Fioruci-Fontanelli, B. A., Mendes, L. O., Ferreira Seiva, F. R., Martinez, M., Fávaro, W. J., Domeniconi, R. F., Pinheiro, P. F., Delazari dos Santos, L., & Martinez, F. E. (2015) · BMC Cancer · doi:10.1186/s12885-015-1032-4 · Cited by 100 · cited 2×
“No effects were found in a single study on TLR2 [144], whereas inhibition of TLR3 was reported [145,146].”
BackgroundRetractedFan, T., Pi, H., Li, M., Ren, Z., He, Z., Zhu, F., Li, T. X., Tu, M., Xie, J., Liu, M., et al. (2017) · Journal of Pineal Research · doi:10.1111/jpi.12457 · Cited by 93
RetractedSu, Z., Zhang, P., Yu, Y., Lu, H., Liu, Y., Ni, P., Su, X., Wang, D., Liu, Y., Wang, J., et al. (2016) · Scientific Reports · doi:10.1038/srep21884 · Cited by 80
RetractedZhang, S., Jiang, L., Che, F., Lu, Y., Xie, Z., & Wang, H. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.08.062 · Cited by 74
RetractedYang, W., Kang, X., Qin, N., Li, F., Jin, X., Ma, Z., Qian, Z., & Wu, S. (2017) · Steroids · doi:10.1016/j.steroids.2017.08.005 · Cited by 28
RetractedWu, C., Huang, Y. X., Pei, Z., Xi, X., & Zhu, G. (2018) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2018.04.019 · Cited by 26
RetractedMiR-125b Inhibits LPS-Induced Inflammatory Injury via Targeting MIP-1α in Chondrogenic Cell ATDC5
Jia, J., Wang, J., Zhang, J., Cui, M., Sun, X., Li, Q., & Zhao, B. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000488178 · Cited by 25
RetractedBu, P., Luo, C., He, Q., Yang, P., Li, X., & Xu, D. (2017) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2017.4595 · Cited by 23
Retracted
Research works printed but not linked: 1
- Hardeland, 2016, Opposite effects of melatonin in different systems and under different conditions, Curr. Top. Biochem. Res., 17, 57
Cited by
COVID-19: Melatonin as a potential adjuvant treatment
Zhang, R., Wang, X., Ni, L., Di, X., Ma, B., Niu, S., Liu, C., & Reiter, R. J. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117583 · Cited by 619
“There may be, however, some concerns about the potential pro-inflammatory actions of melatonin when used in very high doses or under suppressed immune conditions where it may induce an increase production of pro-inflammatory cytokines, IL-1β, IL-2, IL-6, IL-12, TNF-α, and IFN-γ [35] .”
BackgroundInflammaging and Oxidative Stress in Human Diseases: From Molecular Mechanisms to Novel Treatments
Zuo, L., Prather, E. R., Stetskiv, M., Garrison, D. E., Meade, J. R., Peace, T. I., & Zhou, T. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20184472 · Cited by 539
“Melatonin, apart from its circadian roles, is another crucial regulator that can suppress NF-κB activity (Figure 3A) [160].”
BackgroundArioz, B. I., Tastan, B., Tarakcioglu, E., Tufekci, K. U., Olcum, M., Ersoy, N., Bagriyanik, A., Genc, K., & Genc, S. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01511 · Cited by 516
“Inducing effect of melatonin on macrophage and microglia polarization in favor of the anti-inflammatory phenotype M2 is well known (59).”
BackgroundNeuroinflammation in Alzheimer’s Disease
Onyango, I. G., Jauregui, G. V., Čarná, M., Bennett, J. P., & Stokin, G. B. (2021) · Biomedicines · doi:10.3390/biomedicines9050524 · Cited by 330
“polarization towards an M2 phenotype [452].”
BackgroundInflammaging: Implications in Sarcopenia
Antuña, E., Cachán-Vega, C., Bermejo-Millo, J. C., Potes, Y., Caballero, B., Vega-Naredo, I., Coto-Montes, A., & Garcia-Gonzalez, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232315039 · Cited by 215
Metadata
- Authors
- Hardeland, R.
- Affiliations
- University of Göttingen (DE)
- Corresponding author
- Hardeland, Rüdiger
- ORCID
- Hardeland, Rüdiger
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2019-03-11
- Volume
- 20
- Issue
- 5
- Pages
- 1223
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC6429360
- OpenAlex
- W2922219401
- Cited by
- 337
- References
- 412
- Citations by year
- 2026: 21 · 2025: 50 · 2024: 49 · 2023: 52 · 2022: 55 · 2021: 53 · 2020: 46 · 2019: 9
- FWCI
- 4.90
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- GoeScholar The Publication Server of the Georg-August-Universität Göttingen (Georg-August-Universität Göttingen) (submittedVersion, cc-by)
- Topics
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Circadian rhythm and melatonin
- Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- melatonin, aging, inflammation, SIRT1, circadian rhythm, inflammatory cytokines, anti-inflammatory cytokines, Nrf2, NF-κB, M2 macrophage polarization, microglia, microRNA, senescence-associated secretory phenotype, NLRP3 inflammasome, gasdermin D, TLR4, mTOR signaling, amyloid-beta toxicity, age-related diseases
- MeSH terms
- Aging, Animals, Disease Susceptibility, Gene Expression Regulation, Humans, Inflammation, Melatonin, Signal Transduction, Biomarkers, Cytokines, Inflammation Mediators, Gene Regulatory Networks, Inflammasomes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Aging, Melatonin, and the Pro- and Anti-Inflammatory Networks. https://app.cochat.ai/papers/10.3390/ijms20051223
- The paper
- Hardeland, R. (2019). Aging, Melatonin, and the Pro- and Anti-Inflammatory Networks. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms20051223
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.